Indomethacin for Cluster Headache: Not Recommended
Indomethacin should NOT be used for cluster headache, as it is ineffective for this condition and may cause unnecessary adverse effects. Cluster headache is widely recognized as an indomethacin-resistant disorder, and standard cluster headache treatments (oxygen, triptans, verapamil) should be used instead.
Why Indomethacin Doesn't Work for Cluster Headache
The evidence is clear that indomethacin is not effective for cluster headache:
Controlled trial evidence 1: A study of 18 patients with episodic cluster headache receiving indomethacin 100 mg IM every 12 hours showed no protective effect. The mean daily attack frequency remained unchanged (1.6 attacks before vs. 2.1 on day 1 and 1.9 on day 2 after indomethacin). The expected attacks occurred at their usual intervals (mean 4.6 hours) despite therapeutic indomethacin levels, demonstrating no refractory period.
Mechanism of action 2: Electrophysiological studies reveal that while indomethacin uniquely inhibits nitric oxide (NO)-induced neuronal firing (which explains its efficacy in paroxysmal hemicrania and hemicrania continua), this mechanism is not relevant to cluster headache pathophysiology.
The Diagnostic Confusion Problem
Critical caveat: Indomethacin responsiveness is a defining feature of paroxysmal hemicrania and hemicrania continua—NOT cluster headache. If a patient's "cluster headache" responds to indomethacin, you likely have the wrong diagnosis 3, 4.
Distinguishing Features:
Paroxysmal Hemicrania (indomethacin-responsive):
- Attacks: 5-40 per day, lasting 2-30 minutes
- Absolute response to indomethacin (usually 25-75 mg/day)
- More common in women
Cluster Headache (indomethacin-resistant):
- Attacks: 1-8 per day, lasting 15-180 minutes
- No response to indomethacin
- More common in men
- Responds to oxygen, triptans, verapamil prophylaxis
Rare Exceptions and What They Mean
While isolated case reports 5, 3, 6 describe indomethacin response in patients labeled as having cluster headache, these likely represent:
- Misdiagnosis: Many were probably paroxysmal hemicrania misclassified as cluster headache 3
- Atypical presentations: One retrospective study 5 found 29% of 105 chronic cluster headache patients responded to indomethacin (mean dose 86 mg/day), but this was uncontrolled and may reflect diagnostic heterogeneity
- Delayed/incomplete response: When cluster headache patients do respond, it requires higher doses and longer duration than typical indomethacin-responsive headaches 3
What You Should Do Instead
For acute cluster headache treatment:
- High-flow oxygen (12-15 L/min via non-rebreather mask for 15-20 minutes)
- Subcutaneous or intranasal sumatriptan
- Intranasal zolmitriptan
For cluster headache prevention:
- Verapamil (first-line, 240-960 mg/day with EKG monitoring)
- Lithium for chronic cluster headache
- Galcanezumab or other CGRP monoclonal antibodies
- Short-term corticosteroids for cluster period initiation
The INDOTEST: A Diagnostic Tool
If diagnostic uncertainty exists between cluster headache and paroxysmal hemicrania, consider the "INDOTEST" 1: indomethacin 100 mg IM. A true indomethacin-responsive headache will show immediate effect (within hours), while cluster headache will not. This can clarify diagnosis and prevent prolonged inappropriate treatment.
Bottom line: Do not prescribe indomethacin for cluster headache. If it works, reconsider your diagnosis. Use evidence-based cluster headache treatments that actually provide morbidity and mortality benefits through effective pain control and prevention.